Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Ng, Tien M H
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). [electronic resource] - International journal of cardiology May 2006 - 322-8 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
0167-5273
10.1016/j.ijcard.2005.06.038 doi
Acetylcysteine--therapeutic use
Adult
Aged
Cardiac Catheterization
Contrast Media--adverse effects
Female
Fenoldopam--therapeutic use
Humans
Kidney Diseases--chemically induced
Male
Middle Aged
Multivariate Analysis
Prospective Studies
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). [electronic resource] - International journal of cardiology May 2006 - 322-8 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
0167-5273
10.1016/j.ijcard.2005.06.038 doi
Acetylcysteine--therapeutic use
Adult
Aged
Cardiac Catheterization
Contrast Media--adverse effects
Female
Fenoldopam--therapeutic use
Humans
Kidney Diseases--chemically induced
Male
Middle Aged
Multivariate Analysis
Prospective Studies